Distinct oligomeric states of SMAD proteins in the transforming growth factor-β pathway

被引:97
作者
Jayaraman, L
Massagué, J
机构
[1] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA
关键词
D O I
10.1074/jbc.M005799200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein interactions are critical for the function of SMADs as mediators of transforming growth factor-beta (TGF-beta) signals. TGF-beta receptor phosphorylation of SMAD2 or SMAD3 causes their association with SMAD4 and accumulation in the nucleus where the SMAD complex binds cofactors that determine the choice of target genes. We provide evidence that in the basal state, SMADs 2, 3, and 4 form separate, strikingly different complexes. SMAD2 is found mostly as monomer, whereas the closely related SMAD3 exists in multiple oligomeric states. This difference is due to a unique structural element in the MH1 domain of SMAD2 that inhibits protein-protein interactions in the basal state. In contrast to SMAD2 and SMAD3, SMAD4 in the basal state is found mostly as a homo-oligomer, most likely a trimer. Upon cell stimulation with TGF-beta, SMAD proteins become engaged in a multitude of complexes ranging in size from SMAD2-SMAD4 heterodimers to assemblies of >650 kDa, The latter display the highest DNA binding affinity for the TGF-beta -response elements of JUNB and collagen 7. These observations, all validated with endogenous SMAD proteins, modify previous models regarding the assembly and activity of SMAD complexes in the TGF-beta pathway.
引用
收藏
页码:40710 / 40717
页数:8
相关论文
共 33 条
[1]   Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response [J].
Ashcroft, GS ;
Yang, X ;
Glick, AB ;
Weinstein, M ;
Letterio, JJ ;
Mizel, DE ;
Anzano, M ;
Greenwell-Wild, T ;
Wahl, SM ;
Deng, CX ;
Roberts, AB .
NATURE CELL BIOLOGY, 1999, 1 (05) :260-266
[2]   Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-β antiproliferative responses in colon cancer cells [J].
Calonge, MJ ;
Massagué, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33637-33643
[3]   A transcriptional partner for MAD proteins in TGF-beta signalling [J].
Chen, X ;
Rubock, MJ ;
Whitman, M .
NATURE, 1996, 383 (6602) :691-696
[4]   Microtubule binding to Smads may regulate TGFβ activity [J].
Dong, CM ;
Li, ZR ;
Alvarez, R ;
Feng, XH ;
Goldschmidt-Clermont, PJ .
MOLECULAR CELL, 2000, 5 (01) :27-34
[5]   The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation [J].
Feng, XH ;
Zhang, Y ;
Wu, RY ;
Derynck, R .
GENES & DEVELOPMENT, 1998, 12 (14) :2153-2163
[6]  
Germain S, 2000, GENE DEV, V14, P435
[7]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[8]   OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways [J].
Hata, A ;
Seoane, J ;
Lagna, G ;
Montalvo, E ;
Hemmati-Brivanlou, A ;
Massagué, J .
CELL, 2000, 100 (02) :229-240
[9]   Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 [J].
Hata, A ;
Lo, RS ;
Wotton, D ;
Lagna, G ;
Massague, J .
NATURE, 1997, 388 (6637) :82-87
[10]   MADR1, a MAD-related protein that functions in BMP2 signaling pathways [J].
Hoodless, PA ;
Haerry, T ;
Abdollah, S ;
Stapleton, M ;
OConnor, MB ;
Attisano, L ;
Wrana, JL .
CELL, 1996, 85 (04) :489-500